Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.80
Bid: 70.00
Ask: 71.00
Change: 0.60 (0.85%)
Spread: 1.00 (1.429%)
Open: 70.60
High: 70.80
Low: 70.60
Prev. Close: 70.20
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - GCP Asset Backed Income Fund Limited

18 Mar 2024 15:11

RNS Number : 2920H
Brewin Dolphin Limited
18 March 2024
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Brewin Dolphin Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GCP Asset Backed Income Fund Ltd

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15/03/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

NPV ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,615,836

1.55

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

6,615,836

1.55

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

NPV ordinary

NPV ordinary

Sale

Sale

5500

5000

 

 

68.82p

68.82p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

18/03/2024

Contact name:

James Clarke

Telephone number:

0191 230 7202

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEVLFFZXLBBBK
Date   Source Headline
2nd May 20179:25 amRNSInvestor Report as at 31 March 2017
25th Apr 20171:06 pmRNSDividend Declaration
24th Apr 20174:25 pmRNSAnnual General Meeting
20th Apr 20179:32 amRNSNovation of investment management agreement
19th Apr 20177:00 amRNSNet Asset Value(s)
13th Apr 20177:00 amRNSAnnual Report & Financial Statements
7th Apr 201712:36 pmRNSNew Directorship Notification
24th Mar 20177:00 amRNSInvestment commitment of £7 million
10th Mar 20172:55 pmRNSInvestment commitment of £17.5 million
2nd Mar 20172:26 pmRNSHolding(s) in Company
1st Mar 201710:37 amRNSTotal Voting Rights
15th Feb 20174:46 pmRNSHolding(s) in Company
10th Feb 201711:46 amRNSResult of OO, Placing & OFS
8th Feb 20173:39 pmRNSCorrection to Prospectus
25th Jan 20174:46 pmRNSInvestor Report as at 31 December 2016
25th Jan 20179:44 amRNSNon-Mainstream Pooled Investments
20th Jan 20174:05 pmRNSC Share Issue and Publication of Prospectus
18th Jan 20173:55 pmRNSDividend Declaration
13th Jan 20173:22 pmRNSNet Asset Value(s)
13th Jan 20171:39 pmRNSRevolving Credit Facility and further investment
5th Jan 20171:48 pmRNSProposed C Share Issue
23rd Dec 201612:48 pmRNSSocial infrastructure investments of £13.5 million
16th Dec 201611:27 amRNSInvestment commitment of £15.0 million
13th Dec 20163:48 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSTotal Voting Rights
21st Nov 201611:18 amRNSHolding(s) in Company
11th Nov 20163:14 pmRNSHolding(s) in Company
9th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 20167:00 amRNSResult of Placing
2nd Nov 20167:00 amRNSPlacing of New Ordinary Shares
25th Oct 201612:41 pmRNSInvestor Report as at 30 September 2016
20th Oct 20164:19 pmRNSHolding(s) in Company
19th Oct 20161:05 pmRNSReplacement Dividend Declaration
19th Oct 201612:56 pmRNSProposed Equity Raise
19th Oct 201612:51 pmRNSDividend Declaration
18th Oct 20168:00 amRNSTotal Voting Rights & Additional Listing
14th Oct 201611:42 amRNSConversion of C Shares
13th Oct 20168:00 amRNSChange of Name
12th Oct 201611:20 amRNSResult of AGM
11th Oct 20161:34 pmRNSNet Asset Value(s)
3rd Oct 201610:00 amRNSInvestment Completions and C Share Conversion
28th Sep 20167:00 amRNSInterim Financial Report & Financial Statements
9th Sep 201612:35 pmRNSHolding(s) in Company
9th Sep 201612:34 pmRNSHolding(s) in Company
9th Sep 201612:23 pmRNSNotice of AGM & proposed change of company name
24th Aug 20167:00 amRNSInvestment Commitment of c. £13.5 million
5th Aug 20167:00 amRNSHeadline: Investor Report as at 30 June 2016
29th Jul 20164:43 pmRNSNet Asset Value(s)
25th Jul 20164:12 pmRNSHolding(s) in Company
20th Jul 20161:46 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.